ANGO logo

ANGO
Angiodynamic Inc

1,029
Mkt Cap
$515.47M
Volume
272,303.00
52W High
$13.50
52W Low
$6.91
PE Ratio
-15.84
ANGO Fundamentals
Price
$12.40
Prev Close
$12.30
Open
$12.31
50D MA
$11.69
Beta
0.99
Avg. Volume
641,926.35
EPS (Annual)
-$0.8321
P/B
2.87
Rev/Employee
$433,330.37
Loading...
Loading...
News
all
press releases
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised AngioDynamics from a "hold" rating to a "buy" rating in a research note on Friday...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Segall Bryant & Hamill LLC Has $13.46 Million Position in AngioDynamics, Inc. $ANGO
Segall Bryant & Hamill LLC cut its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO
Envestnet Asset Management Inc. cut its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 71.7% during the 2nd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·5d ago
News Placeholder
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
Zacks·8d ago
News Placeholder
Integrated Quantitative Investments LLC Buys New Position in AngioDynamics, Inc. $ANGO
Integrated Quantitative Investments LLC bought a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the second quarter, according to its most recent disclosure with the...
MarketBeat·10d ago
News Placeholder
AngioDynamics, Inc. $ANGO Stock Holdings Decreased by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 49.8% during the 2nd quarter, according to its most recent disclosure...
MarketBeat·13d ago
News Placeholder
AngioDynamics to Participate in the UBS Global Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient...
Business Wire·1mo ago
News Placeholder
AngioDynamics NanoKnife System Named to TIMEs 2025 Best Inventions List
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient...
Business Wire·2mo ago
News Placeholder
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
Zacks·2mo ago
News Placeholder
AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago

Latest ANGO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.